VIMSELTINIB

549 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking VIMSELTINIB:

# Side effect Count
0 FATIGUE 136
1 SWELLING FACE 69
2 PRURITUS 63
3 PERIORBITAL SWELLING 60
4 PERIPHERAL SWELLING 51
5 PRODUCT USE ISSUE 45
6 ARTHRALGIA 42
7 NAUSEA 42
8 RASH 42
9 EYE SWELLING 40
See all common reactions for VIMSELTINIB

VIMSELTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD CREATINE PHOSPHOKINASE MM INCREASED 1 0.0417
1 CREATINE KINASE ABNORMAL 1 0.0417
2 SKIN COSMETIC PROCEDURE 1 0.0159
3 NAIL DEFORMATION 1 0.0149
4 PERIORBITAL INFECTION 1 0.0123
5 PERIORBITAL SWELLING 60 0.0106
6 SWOLLEN TEAR DUCT 1 0.0094
7 CREATINE KINASE INCREASED 7 0.0091
8 TUMOUR INFLAMMATION 1 0.0089
9 ENZYME LEVEL ABNORMAL 1 0.0071
See all enriched reactions for VIMSELTINIB